BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4138624)

  • 61. Non-Hodgkin's lymphomata: clinical and immunological data in relation to histology.
    Dumont J; Duffillot C; Flandrin G; Chelloul N; Tristant H; Bernard
    Br J Cancer Suppl; 1975 Mar; 2():187-200. PubMed ID: 1101917
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
    Zukerberg LR; Collins AB; Ferry JA; Harris NL
    Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracellular immunoglobulins. A comparative study on three standard tissue processing methods using horseradish peroxidase and fluorochrome conjugates.
    Burns J; Hambridge M; Taylor CR
    J Clin Pathol; 1974 Jul; 27(7):548-57. PubMed ID: 4607520
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial.
    Younes A; Berdeja JG; Patel MR; Flinn I; Gerecitano JF; Neelapu SS; Kelly KR; Copeland AR; Akins A; Clancy MS; Gong L; Wang J; Ma A; Viner JL; Oki Y
    Lancet Oncol; 2016 May; 17(5):622-31. PubMed ID: 27049457
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The production of abnormal cells and Reed-Sternberg-like cells from normal lymphocytes.
    Stuart AE
    Br J Cancer; 1983 May; 47(5):713-7. PubMed ID: 6849805
    [No Abstract]   [Full Text] [Related]  

  • 66. Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma.
    Strickler JG; Audeh MW; Copenhaver CM; Warnke RA
    Cancer; 1988 May; 61(9):1782-6. PubMed ID: 3355976
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T-cell/histiocyte-rich large B-cell lymphoma with zonal expansion of fibroblastic reticulum cells and infiltration by a subpopulation of myeloperoxidase positive histiocytes.
    Suárez-Vilela D; Izquierdo FM; Riera-Velasco JR; Burgo PM
    Pathol Res Pract; 2014 Dec; 210(12):1167-70. PubMed ID: 25042387
    [No Abstract]   [Full Text] [Related]  

  • 68. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reed-Sternberg-like cells in lymphocytic lymphoma and chronic lymphocytic leukaemia.
    Schnitzer B
    Lancet; 1970 Jun; 1(7661):1399-400. PubMed ID: 4195066
    [No Abstract]   [Full Text] [Related]  

  • 70. Lymphocyte transformation in malignant lymphomas.
    Papac RJ
    Cancer; 1970 Aug; 26(2):279-86. PubMed ID: 4916021
    [No Abstract]   [Full Text] [Related]  

  • 71. [Various types of malignant lymphomas].
    Hamatol Bluttransfus; 1976; 18():151-66. PubMed ID: 786809
    [No Abstract]   [Full Text] [Related]  

  • 72. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1987 Dec; 40(12):1405-12. PubMed ID: 3323247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phytohemagglutinin induced lymphoblastic transformation and rosette forming T lymphocytes: the relationship to prognosis in advanced malignant lymphoma.
    Srichaikul T; Chaisiripumkeeree W; Aschararit N; Boonpucknavig S
    J Med Assoc Thai; 1979 Jul; 62(7):360-7. PubMed ID: 383870
    [No Abstract]   [Full Text] [Related]  

  • 74. Pathology of the lymphomas.
    Kahn LB
    S Afr Med J; 1972 Aug; 46(33):1153-9. PubMed ID: 4562557
    [No Abstract]   [Full Text] [Related]  

  • 75. [Immunodeficiency and lymphomas].
    Leoni P; Montroni M; Montillo M; Centurioni R; Salvi A; Fanciulli E
    G Clin Med; 1981 Sep; 62(9):648-55. PubMed ID: 7033028
    [No Abstract]   [Full Text] [Related]  

  • 76. Multidisciplinary study of non-Hodgkin lymphomas: electron microscopy, immune- and enzyme-histochemistry.
    Feltkamp CA; Feltkamp-Vroom TM; Koudstaal J; van Heerds P; Spiele H; de Graaf-Reitsma CB
    Adv Exp Med Biol; 1979; 114():545-51. PubMed ID: 380302
    [No Abstract]   [Full Text] [Related]  

  • 77. Functional classification of malignant lymphoma of Lukes and Collins.
    Lukes RJ
    Recent Results Cancer Res; 1978; 64():19-30. PubMed ID: 366697
    [No Abstract]   [Full Text] [Related]  

  • 78. Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.
    Nowoslawski A; Brzosko WJ; Madaliński K; Krawczyński K
    Lancet; 1970 Mar; 1(7645):494-8. PubMed ID: 4190180
    [No Abstract]   [Full Text] [Related]  

  • 79. Evidence of Sternberg-Reed cells being derived from activated lymphocytes.
    Stein H; Gerdes J; Lemke H; Mason DY
    Haematol Blood Transfus; 1985; 29():441-4. PubMed ID: 4029737
    [No Abstract]   [Full Text] [Related]  

  • 80. Lymphoreticular neoplasia in immunosuppression: facts and fancies.
    Krüger GR
    Beitr Pathol; 1974 Mar; 151(3):221-33. PubMed ID: 4600317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.